Results 331 to 340 of about 3,228,085 (398)
Advances and Challenges in Aeromonas hydrophila Vaccine Development: Immunological Insights and Future Perspectives. [PDF]
Miryala KR, Swain B.
europepmc +1 more source
Liver fibrosis is a growing global health burden with no specific treatment. HSC activation is the predominant driver of liver fibrogenesis and the current focus in antifibrotic drug discovery. This study identifies autocrine GDF10 activates BMPR2/ALK3‐SMAD1/5/8‐SMAD7 pathway to counteract the TGF‐β‐SMAD2/3 pathway in HSCs, thereby inhibiting HSC ...
Yinliang Zhang+16 more
wiley +1 more source
Functional Analysis of Mature Activin A Produced by Enterokinase in Plant Cells. [PDF]
Moon KB+7 more
europepmc +1 more source
This study develops lipid nanoparticles (LNPs) combining cationic and ionizable lipids for efficient cytosolic protein delivery. Optimized LNPs deliver functional proteins, including antibodies, enzymes, and Cas9, with high serum stability and albumin‐mediated endocytosis.
Lanfang Ren+6 more
wiley +1 more source
Targeted regulation of pyroptosis to modulate the immune landscape is a novel design strategy for cancer immunotherapy and anti‐inflammatory treatment. Pyroptosis, as a double‐edged sword, underscores the importance of optimizing the design strategy of functional materials and appropriately activating pyroptosis for the effective treatment of diseases.
Luyao Tian+5 more
wiley +1 more source
Advancements in the application and research of baculovirus vector vaccines for respiratory diseases in human. [PDF]
Yuan J+11 more
europepmc +1 more source
This study identifies TREM2+ macrophages as key contributors to pathological bone formation in ankylosing spondylitis (AS). These macrophages mediate pathological new bone formation via the CREG1‐IGF2R‐PI3K‐AKT pathway and are regulated by IL‐33 through STAT6 phosphorylation.
Wenjun Hao+16 more
wiley +1 more source
Achievement and Challenges in Orthohantavirus Vaccines. [PDF]
Chai S, Wang L, Du H, Jiang H.
europepmc +1 more source
Viral protease binds to nucleosomal DNA and cleaves nuclear cGAS that attenuates type I interferon. [PDF]
Wu L+8 more
europepmc +1 more source